These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 225425)

  • 1. Isolation and characterization of trypsin-resistant O1 variants of foot-and-mouth disease virus.
    Barteling SJ; Meloen RH; Wagenaar F; Gielkens AL
    J Gen Virol; 1979 May; 43(2):383-93. PubMed ID: 225425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The positively charged structural virus protein (VP1) of foot-and-mouth disease virus (type O1) contains a highly basic part which may be involved in early virus-cell interaction.
    Barteling SJ; Wagenaar F; Gielkens AL
    J Gen Virol; 1982 Oct; 62 (Pt 2)():357-61. PubMed ID: 6292355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the minor polypeptides in the foot-and-mouth disease particle.
    Sangar DV; Rowlands DJ; Cavanagh D; Brown F
    J Gen Virol; 1976 Apr; 31(1):35-46. PubMed ID: 177728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of trypsin treatment on the antigenic characteristics of plaque variants of type-O 1 and type Asia-1 foot-and-mouth disease viruses.
    Cowan KM; Erol N; Whiteland AP
    J Gen Virol; 1978 Nov; 41(2):437-42. PubMed ID: 82610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of trypsin and chymotrypsin on the polypeptides of large and small plaque variants of foot-and-mouth disease virus: relationship to specific antigenicity and infectivity.
    Moore DM; Cowan KM
    J Gen Virol; 1978 Dec; 41(3):549-62. PubMed ID: 84854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function relationships in foot-and-mouth disease virus.
    Brown F
    Adv Exp Med Biol; 1972; 31(0):19-28. PubMed ID: 4369223
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative chemical and serological study of the full and empty particles of foot-and mouth disease virus.
    Rowlands DJ; Sangar DV; Brown F
    J Gen Virol; 1975 Mar; 26(3):227-38. PubMed ID: 235596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localisation on foot-and-mouth disease virus (FMDV) of an antigenic deficiency induced by passage in BHK cells.
    Meloen RH
    Arch Virol; 1976; 51(4):299-306. PubMed ID: 184763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an exposed region of the immunogenic capsid polypeptide VP1 on foot-and-mouth disease virus.
    Robertson BH; Moore DM; Grubman MJ; Kleid DG
    J Virol; 1983 Apr; 46(1):311-6. PubMed ID: 6186823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical aspects of variation in foot-and-mouth disease virus.
    Robson KJ; Doel TR; Gorman BM; Brown F
    J Gen Virol; 1980 Jan; 46(1):179-93. PubMed ID: 6243341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The main antigenic determinant detected by neutralizing monoclonal antibodies on the intact foot-and-mouth disease virus particle is absent from isolated VPI.
    Meloen RH; Briaire J; Woortmeyer RJ; van Zaane D
    J Gen Virol; 1983 May; 64(Pt 5):1193-8. PubMed ID: 6188800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface structure of foot-and-mouth disease virus.
    Wild TF; Burroughs JN; Brown F
    J Gen Virol; 1969 Apr; 4(3):313-20. PubMed ID: 4306712
    [No Abstract]   [Full Text] [Related]  

  • 13. Location of an immunizing determinant within polypeptide VP1 of type O aphthovirus.
    Haresnape JM; King AM; McCahon D
    J Gen Virol; 1983 Nov; 64 (Pt 11)():2357-65. PubMed ID: 6196439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenic and cell attachment sites of FMDV: further evidence for their location in a single capsid polypeptide.
    Cavanagh D; Sangar DV; Rowlands DJ; Brown F
    J Gen Virol; 1977 Apr; 35(1):149-58. PubMed ID: 192841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of a neutralization epitope of foot-and-mouth disease virus using neutralizing monoclonal antibodies.
    Duchesne M; Cartwright T; Crespo A; Boucher F; Fallourd A
    J Gen Virol; 1984 Sep; 65 ( Pt 9)():1559-66. PubMed ID: 6206202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical analysis of a virulent and an avirulent strain of foot-and-mouth disease virus.
    Harris TJ; Brown F
    J Gen Virol; 1977 Jan; 34(1):87-105. PubMed ID: 188983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
    Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
    Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host cell selection of antigenic variants of foot-and-mouth disease virus.
    Bolwell C; Brown AL; Barnett PV; Campbell RO; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():45-57. PubMed ID: 2471782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of antigenic variants of foot-and-mouth disease virus by polyacrylamide gel electrophoresis of their structural polypeptides.
    Knowles NJ; Hedger RS
    Vet Microbiol; 1985 Jun; 10(4):347-57. PubMed ID: 2412337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface structure and RNA-protein interactions of foot-and-mouth disease virus.
    Morrell DJ; Mellor EJ; Rowlands DJ; Brown F
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1649-58. PubMed ID: 3035064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.